Clinical trial
Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-Acquired Pneumonia
NCT02880384 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-Acquired Pneumonia
- Lead sponsor
- Providence Health & Services
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2017
- Completion date
- December 20, 2020
- Enrollment
- 570 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
community acquired pneumonia